Pixantrone tops doxorubicin for non-Hodgkin's lymphoma

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1619, 2008-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma

By Jamal-Hanjani Mariam Pettengell Ruth

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1441-1448

Informa Healthcare

Access to resources Recommend Favorite

Pixantrone for the treatment of aggressive non-Hodgkin lymphoma

By Mukherji Deborah Pettengell Ruth

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1915-1923

Informa Healthcare

Access to resources Recommend Favorite

The role of pixantrone in the treatment of non-Hodgkin’s lymphoma

By Borchmann Peter

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 8, 2005-08 ,pp. : 1055-1061

Informa Healthcare

Access to resources Recommend Favorite

Non-Hodgkin's Lymphoma in the Elderly

By Caimi Paolo F. Barr Paul M. Berger Nathan A. Lazarus Hillard M.

Drugs & Aging, Vol. 27, Iss. 3, 2010-03 ,pp. : 211-238

Adis International

Access to resources Recommend Favorite

Non-Hodgkin's lymphoma

By Rule Simon

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 362-364

Royal College Of Physicians

Access to resources Recommend Favorite